| (210) | Number of the EPO application | 17701596 |
| (220) | Filing date of the EPO application | 2017.01.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 43/2020, 2020.10.21 |
| (110) | EPO patent number | 3402503 |
| (21) | Number of the application | e 2018 1121 |
| (71) | Name(s) of applicant(s), code of the country | Acerta Pharma B.V., NL; |
| (72) | Name(s) of inventor(s), code of the country | KAPTEIN Allard, NL;
ROTHBAUM Wayne, US;
LANNUTTI Brian, US; |
| (73) | Name(s) of owner(s), code of the country | ACERTA Pharma B.V., NL; |
| (54) | Title of the invention | THERAPEUTIC COMBINATIONS OF AN ANTIFOLATE AND A BTK INHIBITOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/00 (2006.01.01); A61K 39/00 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/522 (2006.01.01); A61K 31/52 (2006.01.01); A61K 31/519 (2006.01.01); A61K 31/517 (2006.01.01); A61K 31/4985 (2006.01.01); A61K 31/454 (2006.01.01); A61K 45/06 (2006.01.01); A61P 19/02 (2006.01.01) |
| (19) | Country | NL |
| (41) | Date of publication of the application | 2019.01.31 |
| (30) | Priority | 201662278374 P, 2016.01.13, US; 201662371626 P, 2016.08.05, US |
| (86) | International application | PCT/IB2017/050198, 2017.01.13 |
| (87) | International publication | WO 2017/122175, 2017.07.20 |